Home mechanical ventilator treatment for chronic obstructive pulmonary disease patients with chronic hypercapnia
Becker H, Bossios A, Daxberg E, Eriksson M, Hemlin M, Jivegård L, Persson J, Svedmyr S, Sjögren P
Record ID 32016000605
English
Authors' recommendations:
standard treatment for hypercapnic chronic obstructive pulmonary disease (COPD) patients at the Sahlgrenska University Hospital.
The present analysis suggests that NIV may slightly reduce mortality, may improve HRQoL and dyspnoea, and may result in little or no difference in sleep efficiency, hospitalisation, exacerbations and 6MWT (GRADE++00). For an estimated 23 patients the total change in cost by using NIV in hypercapnic COPD patients is estimated to 896,000 SEK during 2016. There are no serious side effects of the treatment.
Details
Project Status:
Completed
Year Published:
2015
URL for published report:
https://www2.sahlgrenska.se/upload/SU/HTA-centrum/HTA-rapporter/HTA%20rapport%20KOL%202%202015-12-15%20%20till%20publicering.pdf
URL for additional information:
http://www.sahlgrenska.se/sv/SU/Forskning/HTA-centrum/Hogerkolumn-undersidor/Publicerade-rapporter/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
MeSH Terms
- Humans
- Chronic Disease
- Hypercapnia
- Pulmonary Disease, Chronic Obstructive
- Ventilators, Mechanical
Contact
Organisation Name:
The Regional Health Technology Assessment Centre
Contact Address:
The Regional Health Technology Assessment Centre, Region Vastra Gotaland, HTA-centrum, Roda Straket 8, Sahlgrenska Universitetssjukhuset, 413 45 GOTHENBORG, Sweden
Contact Name:
hta-centrum@vgregion.se
Contact Email:
hta-centrum@vgregion.se
Copyright:
The Regional Health Technology Assessment Centre (HTA-centrum), Region Vastra Gotaland
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.